photo free
Home Images Vectors Videos

Stock image Alogliptin

stock image Alogliptin molecular structure isolated on black

Alogliptin Molecular Structure Isolated On Black

Image, 0.54MB, 7000 × 3038 jpg
stock image Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA box of medication with ALOGLIPTIN active substance by TAKEDA,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA Box Of Medication With ALOGLIPTIN Active Substance By TAKEDA,used For Treatment Of Type 2 Diabetes

Image, 2.04MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.28MB, 4032 × 3024 jpg
stock image Alogliptin molecular structure isolated on white

Alogliptin Molecular Structure Isolated On White

Image, 0.51MB, 7000 × 3038 jpg
stock image Alogliptin molecular structure isolated on grey

Alogliptin Molecular Structure Isolated On Grey

Image, 0.48MB, 7000 × 3038 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.53MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.36MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA box of medication with ALOGLIPTIN active substance by TAKEDA,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA Box Of Medication With ALOGLIPTIN Active Substance By TAKEDA,used For Treatment Of Type 2 Diabetes

Image, 2.01MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.39MB, 4032 × 3024 jpg
stock image Alogliptin molecular structure isolated on white

Alogliptin Molecular Structure Isolated On White

Image, 0.49MB, 7000 × 3038 jpg
stock image Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA box of medication with ALOGLIPTIN active substance by TAKEDA,used for treatment of type 2 diabetes

Prague,Czech Republic-August 7 2024: VIPIDIA TAKEDA Box Of Medication With ALOGLIPTIN Active Substance By TAKEDA,used For Treatment Of Type 2 Diabetes

Image, 2.07MB, 4032 × 3024 jpg
stock image Prague,Czech Republic-August 10 2024: VIPIDOMET box of medication with ALOGLIPTIN and METFORMIN active substances by TAKEDA,used for treatment of type 2 diabetes.

Prague,Czech Republic-August 10 2024: VIPIDOMET Box Of Medication With ALOGLIPTIN And METFORMIN Active Substances By TAKEDA,used For Treatment Of Type 2 Diabetes.

Image, 2.4MB, 4032 × 3024 jpg
Page 1 >> Next